Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “gastrointestinal osmotic effect” describes the process by which non-absorbable or poorly absorbed solutes in the gut lumen create an osmotic gradient that draws water into the intestinal lumen. This effect increases bowel water content, decreases absorption of solutes and water, and can result in diarrhea if excessive. Common causes include malabsorption of carbohydrates (such as lactose or sorbitol) and the use of osmotic laxatives, which are drugs designed to deliberately trigger this effect to relieve constipation. The process is not mediated by a specific protein or receptor, but can be modulated by various physiological factors, such as intestinal motility, microbiota, aquaporin water channels, and the integrity of the mucosa. It plays a role in gastrointestinal disorders such as osmotic diarrhea, and it is leveraged therapeutically in the management of constipation
Drugs or poorly-absorbed solutes increase luminal osmolality, drawing water into the intestine by osmosis and promoting bowel movement or diarrhea
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal osmotic effect.